ELIspot and ICS analysis of Non-Human Primate samples generated under Janssen (DS-REF-129289: Immunogenicity of SLA-LSQ adjuvant formulations in non-human primates)

Texas Biomedical Research Institute

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)

Giavedoni, Luis D.

Collaborating Institutions

Janssen Pharmaceuticals Inc.

Funded by

Biomedical Advanced Research and Development Authority

Research Start Date

04/01/2019

Status

Active

The major objective is to perform ELISPOT and ICS analysis for the UVF vaccine associated with project ImmunogenicityofSLA-LSQ adjuvant formulations in non-human primates.

Collaborative Project

Basic Research

Infectious Disease

Bioscience Research Panel

ELIspot and ICS analysis of Non-Human Primate samples generated under Janssen (DS-REF-129289: Immunogenicity of SLA-LSQ adjuvant formulations in non-human primates)